Cytokinetics Stock Price History
| CYTK Stock | USD 44.91 0.55 1.24% |
Below is the normalized historical share price chart for Cytokinetics extending back to April 29, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cytokinetics stands at 44.91, as last reported on the 18th of March 2025, with the highest price reaching 44.91 and the lowest price hitting 44.36 during the day.
If you're considering investing in Cytokinetics Stock, it is important to understand the factors that can impact its price. Cytokinetics secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. Cytokinetics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cytokinetics' Standard Deviation of 3.17, mean deviation of 2.14, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide.
At this time, Cytokinetics' Stock Based Compensation is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 742.2 M this year, although the value of Common Stock will most likely fall to about 111.4 K. . At this time, Cytokinetics' Price To Sales Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 2.69 this year, although the value of Price To Operating Cash Flows Ratio is projected to rise to (12.64). Cytokinetics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of April 2004 | 200 Day MA 51.8172 | 50 Day MA 46.4632 | Beta 0.951 |
Cytokinetics |
Sharpe Ratio = -4.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CYTK |
Estimated Market Risk
| 3.29 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cytokinetics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cytokinetics by adding Cytokinetics to a well-diversified portfolio.
Price Book 60.3093 | Enterprise Value Ebitda (15.82) | Price Sales 284.33 | Shares Float 117.7 M | Wall Street Target Price 79.1 |
Cytokinetics Stock Price History Chart
There are several ways to analyze Cytokinetics Stock price data. The simplest method is using a basic Cytokinetics candlestick price chart, which shows Cytokinetics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 20, 2025 | 51.12 |
| Lowest Price | February 11, 2025 | 41.56 |
Cytokinetics March 18, 2025 Stock Price Synopsis
Various analyses of Cytokinetics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cytokinetics Stock. It can be used to describe the percentage change in the price of Cytokinetics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cytokinetics Stock.| Cytokinetics Price Rate Of Daily Change | 1.01 | |
| Cytokinetics Price Action Indicator | 0.55 | |
| Cytokinetics Price Daily Balance Of Power | 1.00 |
Cytokinetics March 18, 2025 Stock Price Analysis
Cytokinetics Stock Price History Data
The price series of Cytokinetics for the period between Wed, Dec 18, 2024 and Tue, Mar 18, 2025 has a statistical range of 9.56 with a coefficient of variation of 5.5. The prices are distributed with arithmetic mean of 47.03. The median price for the last 90 days is 47.15. The company had 1:6 stock split on 25th of June 2013.| Open | High | Low | Close | Volume | ||
03/18/2025 | 44.36 | 44.91 | 44.36 | 44.91 | ||
| 03/17/2025 | 44.25 | 45.52 | 43.78 | 44.91 | 1,189,106 | |
| 03/14/2025 | 44.84 | 45.00 | 43.52 | 44.36 | 1,337,107 | |
| 03/13/2025 | 43.74 | 44.43 | 42.54 | 44.40 | 994,622 | |
| 03/12/2025 | 44.77 | 45.07 | 43.55 | 43.99 | 1,872,901 | |
| 03/11/2025 | 43.46 | 44.91 | 42.04 | 44.40 | 1,967,348 | |
| 03/10/2025 | 43.28 | 44.76 | 42.87 | 43.31 | 1,674,630 | |
| 03/07/2025 | 43.10 | 44.18 | 42.55 | 43.43 | 1,741,467 | |
| 03/06/2025 | 43.27 | 45.00 | 42.23 | 43.27 | 1,107,267 | |
| 03/05/2025 | 43.53 | 44.08 | 42.47 | 43.88 | 1,252,284 | |
| 03/04/2025 | 42.50 | 44.58 | 41.92 | 43.69 | 1,787,869 | |
| 03/03/2025 | 46.00 | 46.58 | 42.61 | 42.89 | 1,864,365 | |
| 02/28/2025 | 44.36 | 46.95 | 42.87 | 46.00 | 2,017,137 | |
| 02/27/2025 | 47.04 | 48.54 | 46.91 | 47.45 | 1,201,590 | |
| 02/26/2025 | 47.14 | 47.80 | 46.17 | 46.86 | 984,423 | |
| 02/25/2025 | 48.67 | 48.67 | 46.06 | 46.65 | 1,858,865 | |
| 02/24/2025 | 50.27 | 50.98 | 48.10 | 48.14 | 1,420,334 | |
| 02/21/2025 | 51.57 | 51.74 | 48.88 | 50.26 | 2,169,437 | |
| 02/20/2025 | 46.61 | 51.39 | 46.00 | 51.12 | 2,788,323 | |
| 02/19/2025 | 45.20 | 46.74 | 45.05 | 46.40 | 1,749,420 | |
| 02/18/2025 | 45.60 | 48.30 | 45.38 | 45.39 | 1,779,242 | |
| 02/14/2025 | 41.54 | 46.26 | 40.77 | 46.16 | 4,820,448 | |
| 02/13/2025 | 43.00 | 43.16 | 41.58 | 41.62 | 1,556,616 | |
| 02/12/2025 | 40.65 | 42.33 | 40.53 | 42.18 | 1,785,930 | |
| 02/11/2025 | 42.05 | 43.05 | 41.47 | 41.56 | 1,186,247 | |
| 02/10/2025 | 42.90 | 43.86 | 41.71 | 42.21 | 2,616,099 | |
| 02/07/2025 | 46.23 | 46.23 | 42.72 | 42.76 | 3,642,937 | |
| 02/06/2025 | 50.39 | 50.82 | 45.70 | 46.17 | 3,901,178 | |
| 02/05/2025 | 49.82 | 51.63 | 49.57 | 50.41 | 897,204 | |
| 02/04/2025 | 48.06 | 49.26 | 47.71 | 49.20 | 1,319,037 | |
| 02/03/2025 | 48.47 | 49.72 | 48.15 | 48.47 | 680,432 | |
| 01/31/2025 | 49.68 | 50.49 | 48.27 | 49.46 | 1,099,055 | |
| 01/30/2025 | 48.93 | 50.53 | 48.48 | 49.97 | 1,139,404 | |
| 01/29/2025 | 48.61 | 49.78 | 48.07 | 48.65 | 766,272 | |
| 01/28/2025 | 50.00 | 50.00 | 48.68 | 48.70 | 862,847 | |
| 01/27/2025 | 51.02 | 52.80 | 49.21 | 49.94 | 1,338,548 | |
| 01/24/2025 | 47.75 | 51.16 | 47.60 | 50.75 | 2,100,151 | |
| 01/23/2025 | 46.33 | 47.90 | 44.92 | 47.86 | 1,639,243 | |
| 01/22/2025 | 46.52 | 47.62 | 46.26 | 46.82 | 1,358,448 | |
| 01/21/2025 | 45.92 | 46.32 | 45.26 | 45.82 | 1,255,095 | |
| 01/17/2025 | 47.29 | 47.42 | 45.51 | 45.74 | 998,338 | |
| 01/16/2025 | 46.83 | 47.61 | 46.49 | 46.99 | 792,149 | |
| 01/15/2025 | 46.39 | 48.45 | 45.77 | 46.87 | 1,174,353 | |
| 01/14/2025 | 47.01 | 47.30 | 44.79 | 45.23 | 1,388,797 | |
| 01/13/2025 | 46.65 | 47.04 | 44.49 | 46.71 | 1,288,575 | |
| 01/10/2025 | 46.40 | 47.10 | 45.17 | 46.62 | 1,758,065 | |
| 01/08/2025 | 48.01 | 48.49 | 47.19 | 47.37 | 904,195 | |
| 01/07/2025 | 49.32 | 49.96 | 48.07 | 48.51 | 1,266,112 | |
| 01/06/2025 | 49.20 | 49.80 | 48.77 | 49.19 | 761,956 | |
| 01/03/2025 | 49.04 | 50.15 | 49.04 | 49.36 | 1,007,666 | |
| 01/02/2025 | 48.19 | 49.50 | 47.76 | 48.93 | 865,654 | |
| 12/31/2024 | 47.50 | 47.78 | 46.80 | 47.04 | 798,176 | |
| 12/30/2024 | 47.00 | 47.79 | 46.52 | 47.15 | 1,043,344 | |
| 12/27/2024 | 48.13 | 48.85 | 47.22 | 47.36 | 902,043 | |
| 12/26/2024 | 48.14 | 48.95 | 47.99 | 48.54 | 942,089 | |
| 12/24/2024 | 48.85 | 49.11 | 48.00 | 48.53 | 318,992 | |
| 12/23/2024 | 49.18 | 49.99 | 47.72 | 48.95 | 1,198,329 | |
| 12/20/2024 | 46.85 | 50.32 | 46.85 | 48.87 | 3,805,285 | |
| 12/19/2024 | 46.45 | 47.30 | 45.66 | 46.74 | 1,377,389 | |
| 12/18/2024 | 48.00 | 49.40 | 46.00 | 46.36 | 1,587,183 | |
| 12/17/2024 | 48.50 | 49.04 | 47.38 | 47.78 | 1,372,426 |
About Cytokinetics Stock history
Cytokinetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cytokinetics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cytokinetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cytokinetics stock prices may prove useful in developing a viable investing in Cytokinetics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 112 M | 117.6 M | |
| Net Loss | -350.1 M | -332.6 M |
Cytokinetics Quarterly Net Working Capital |
|
Cytokinetics Stock Technical Analysis
Cytokinetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Cytokinetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cytokinetics' price direction in advance. Along with the technical and fundamental analysis of Cytokinetics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cytokinetics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | 0.2254 | |||
| Treynor Ratio | (0.63) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytokinetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.26) | Revenue Per Share | Quarterly Revenue Growth 9.124 | Return On Assets | Return On Equity |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytokinetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.